Literature DB >> 12832554

Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses.

Tracy L Bale1, Wylie W Vale.   

Abstract

Depressive disorders affect nearly 19 million American adults, making depression and the susceptibility for developing depression a critical focus of mental health research today. Females are twice as likely to develop depression as males. Stress is a known risk factor for developing depression, and recent hypotheses suggest an involvement of an overactive stress axis. As mediators of the stress response, corticotropin-releasing factor (CRF) and its receptors (CRFR1 and CRFR2) have been implicated in the propensity for developing stress-related mood disorders. Mice deficient in CRFR2 display increased anxiety-like behaviors and a hypersensitive stress response. As a possible animal model of depression, these mice were tested for depression-like behaviors in the forced swim test. Comparisons were made between wild-type and mutant animals, as well as between sexes. Male and female CRFR2-mutant mice showed increased immobility as an indicator of depression compared with wild-type mice of the same sex. In addition, mutant and wild-type female mice demonstrated increased immobile time compared with males of the same genotype. Treatment of CRFR2-deficient mice with the CRFR1 antagonist antalarmin decreased immobile time and increased swim time in both sexes. We found a significant effect of sex for both time spent immobile and swimming after antalarmin treatment. Because differences in behaviors in the forced swim test are good indicators of serotonergic and catecholaminergic involvement, our results may reveal an interaction of CRF pathways with other known antidepressant systems and may also support an involvement of CRF receptors in the development of depression such that elevated CRFR1 activity, in the absence of CRFR2, increases depression-like behaviors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12832554      PMCID: PMC6741155     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  63 in total

1.  Central infusion of ovine CRF (oCRF) potentiates defensive behaviors in CD-1 mice in the Mouse Defense Test Battery (MDTB).

Authors:  Mu Yang; Catherine Farrokhi; Amy Vasconcellos; Robert J Blanchard; D Caroline Blanchard
Journal:  Behav Brain Res       Date:  2006-04-18       Impact factor: 3.332

Review 2.  Evidence for the role of corticotropin-releasing factor in major depressive disorder.

Authors:  R Parrish Waters; Marion Rivalan; D A Bangasser; J M Deussing; M Ising; S K Wood; F Holsboer; Cliff H Summers
Journal:  Neurosci Biobehav Rev       Date:  2015-08-10       Impact factor: 8.989

3.  Is it all in the family? The effects of early social structure on neural-behavioral systems of prairie voles (Microtus ochrogaster).

Authors:  G D Greenberg; J A van Westerhuyzen; K L Bales; B C Trainor
Journal:  Neuroscience       Date:  2012-05-01       Impact factor: 3.590

4.  Corticotropin-releasing factor, serotonin, and sex: keys to the castle of depressive illness.

Authors:  James I Koenig
Journal:  Endocrinology       Date:  2009-08       Impact factor: 4.736

Review 5.  Role of corticotropin releasing factor in anxiety disorders: a translational research perspective.

Authors:  Victoria B Risbrough; Murray B Stein
Journal:  Horm Behav       Date:  2006-07-25       Impact factor: 3.587

6.  Corticotropin releasing hormone receptor 2 (CRHR-2) gene is associated with decreased risk and severity of posttraumatic stress disorder in women.

Authors:  Erika J Wolf; Karen S Mitchell; Mark W Logue; Clinton T Baldwin; Annemarie F Reardon; Donald E Humphries; Mark W Miller
Journal:  Depress Anxiety       Date:  2013-10-09       Impact factor: 6.505

7.  Maternal profiling of corticotropin-releasing factor receptor 2 deficient mice in association with restraint stress.

Authors:  Kimberly L D'Anna; Sharon A Stevenson; Stephen C Gammie
Journal:  Brain Res       Date:  2008-09-04       Impact factor: 3.252

Review 8.  Examining the intersection of sex and stress in modelling neuropsychiatric disorders.

Authors:  N Goel; T L Bale
Journal:  J Neuroendocrinol       Date:  2009-03       Impact factor: 3.627

9.  Disruption of the CRF(2) receptor pathway decreases the somatic expression of opiate withdrawal.

Authors:  Francesco Papaleo; Sandy Ghozland; Manuela Ingallinesi; Amanda J Roberts; George F Koob; Angelo Contarino
Journal:  Neuropsychopharmacology       Date:  2008-02-20       Impact factor: 7.853

10.  Suppression of the MEK/ERK signaling pathway reverses depression-like behaviors of CRF2-deficient mice.

Authors:  Cedomir Todorovic; Tessi Sherrin; Matthew Pitts; Cathrin Hippel; Martin Rayner; Joachim Spiess
Journal:  Neuropsychopharmacology       Date:  2008-10-08       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.